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a  b  s  t  r  a  c  t
The  African  buffalo  (Syncerus  caffer)  is  considered  the  most  important  maintenance  host  of  bovine
tuberculosis  (BTB)  in wildlife  in  Southern  Africa.  The  diagnosis  of  Mycobacterium  bovis  infection  in  this
species  mostly  relies  on the single  intradermal  comparative  tuberculin  test (SICTT).  As  an  alternative,  the
BOVIGAM® 1G, an interferon-gamma  (IFN-)  release  assay,  is  frequently  used.  The  test  performance  of
cell-mediated  immunity  (CMI-)  and  humoral  immunity  (HI-)  based  assays  for  the  detection  of  M.  bovis
infections  in  buffaloes  was compared  to  identify  the  test  or test  combination  that  provided  the  highest
sensitivity  in the study.  Buffaloes  were  sampled  during  the  annual  BTB  SICTT  testing  in  the  Hluhluwe-
iMfolozi-Park  (KwaZulu-Natal,  South  Africa)  during  June  2013.  A total  of  35 animals  were  subjected  to  the
SICTT,  13  of these  tested  positive  and one  showed  an  inconclusive  reaction.  CMI-based  assays  (BOVIGAM®
1G (B1G)  and BOVIGAM® 2G  (B2G))  as  well  as  a serological  assay  (IDEXX  TB  ELISA)  were  used  to  further
investigate  and  compare  immune  responsiveness.  Thirteen  SICTT  positive  buffaloes  and one  inconclusive
reactor  were  slaughtered  and  a  post-mortem  (PM)  examination  was  conducted  to conﬁrm  BTB.  Lesions
characteristic  of BTB  were  found  in  8/14  animals  (57.1%).  Test  results  of individual  assays  were  compared
with  serial  and  parallel  test  interpretation  and  the  sensitivity  was  calculated  as a percentage  of  test  posi-
tives  out of the  number  of  SICTT  positive  animals  with  granulomatous  lesions  (relative  sensitivity).  The
B1G  assay  showed  the  highest  individual  sensitivity  (100%;  8/8)  followed  by  the  B2G assay  (75%; 6/8)  and
the  IDEXX  TB ELISA  (37.5%;  3/8). Therefore,  using  in  parallel  interpretation,  any  combination  with  the  B1G
showed  a sensitivity  of  100%  (8/8),  whereas  combinations  with  the  B2G  showed  a 75%  sensitivity  (6/8).
Out  of  the  21  SICTT  negative  animals,  7 animals  showed  responsiveness  in  the  B2G  or IDEXX  TB ELISA.  In
conclusion,  this  study  has shown  that  the  BOVIGAM® IFN-  assay  had  the  highest  test  performance.
©  2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-NDAbbreviations: B1G, BOVIGAM® 1G; B2G, BOVIGAM® 2G; BTB, bovine
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erium avium;  PPD-B, puriﬁed protein derivative of Mycobacterium bovis; PPD-F,
uriﬁed protein derivative of Mycobacterium fortuitum; PWM,  pokeweed mitogen;
D, region of difference; SICTT, single intradermal comparative tuberculin test; S/P,
ample/positive control; TB, tuberculosis.
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1. Introduction
Tuberculosis is a debilitating, chronic, infectious disease that
may be caused by any of several closely related bacilli of the
Mycobacterium tuberculosis complex (MTBC) (O’Reilly and Daborn,
1995) and remains a major global health issue today (World Health
Organization, 2014). Mycobacterium bovis (M.  bovis), the MTBC
species with the broadest host range and a zoonotic agent is
the main causative agent of bovine tuberculosis (BTB) in cattle
(O’Reilly and Daborn, 1995). The African buffalo (Syncerus caffer)
is considered the most important maintenance host of M. bovis in
Southern Africa and as most mammals are susceptible, the list of
spillover hosts is rather extensive and includes several valuable
species of wildlife (de Lisle et al., 2002, Michel et al., 2006, Renwick
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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t al., 2007). The endemic occurrence of M.  bovis infections in the
luhluwe-iMfolozi-Park (HiP) and the Kruger National Park (KNP)
n South Africa together with the fact that the prevalence of BTB
as been rising has grave implications as it is likely to compromise
i) conservation efforts, especially so in vulnerable or endangered
pecies (Espie et al., 2009), (ii) BTB control efforts in cattle due to
pillback from buffaloes (Musoke et al., 2015), (iii) public health
ue to the risk of zoonotic tuberculosis (TB) (Muller et al., 2013)
nd (iv) (inter-) national trade due to stringent restrictions on trade
n wildlife from BTB infected parks (Michel et al., 2006).
The diagnosis of Mycobacterium bovis infection in buffaloes
ostly relies on the single intradermal comparative tuberculin test
SICTT) (Michel et al., 2011, DAFF, RSA, 2013). The SICTT, how-
ver, comes with several drawbacks as sensitivity and speciﬁcity
re known to be highly variable (Monaghan et al., 1994, de la
ua-Domenech et al., 2006) and the animals need to be held in
aptivity for a minimum of 72 h and chemically manipulated twice
Grobler et al., 2002). The interferon-gamma (IFN-) release assay
BOVIGAM® 1G (B1G)) is increasingly used for diagnosis of M.
ovis infections in cattle and has been optimized for application
n African buffaloes by Michel et al. (2011). This improved proto-
ol has offered the opportunity to achieve higher test speciﬁcity
93.9%) by the introduction of PPD-F (puriﬁed protein derivative
f M.  fortuitum) as a locally representative antigen preparation
f non-tuberculous mycobacteria (NTM) (Michel et al., 2011). The
OVIGAM® 2G (B2G) assay was designed to increase speciﬁcity by
nclusion of peptide cocktails comprised of antigens encoded in the
D1 (region of difference) gene region considered to be unique for
TBC species; PC-EC contains ESAT-6- and CFP-10-derived pep-
ides (Life Technologies, 2015a) and PC-HP additionally contains 4
ycobacterial genes (including Rv3615 (Goosen et al., 2014)) (Life
echnologies, 2015b). In order to effectively monitor and control
TB it is of utmost importance that diagnostic assays are available
hich are accurate and ﬁt for the test purpose. Furthermore, these
ssays should allow for adaptive test interpretation when differ-
nt epidemiological settings require either optimum sensitivity or
peciﬁcity. In the HiP, the purpose of the BTB monitoring program
s to reduce overall and herd prevalence of BTB in the park (Michel
t al., 2006), requiring highly sensitive diagnostics.
The objective of the current study was to assess the array of
iagnostic options currently available commercially for the detec-
ion of M.  bovis infection in buffaloes, in order to identify the test or
est combination that could achieve the highest sensitivity, relative
o the SICTT.
. Materials and methods
.1. Location
The Hluhluwe-iMfolozi Park is situated in the KwaZulu-Natal
rovince of South Africa and covers approximately 96,000 ha
Ezemvelo KZN Wildlife, 2015). There are approximately 5,600 free-
oaming African buffaloes in the park. The buffalo holding bomas
ere set up at the Nselweni site next to the permanent bomas in
he iMfolozi section of the park (28◦18′05.7′′S 31◦53′29.3′′E).
.2. Capture and immobilisation procedure
Animals were mass captured using a plastic boma set-up (Kock
nd Burroughs, 2012) on day 0. Prior to handling, all animals were
mmobilized using a mixture of the opioid derivative etorphine
ydrochloride (M99, Novartis Animal Health, Isando, South Africa)
nd the butyrophenone tranquilizer azaperone (Stresnil, Janssen
harmaceutica, Woodmead, South Africa). Animals were then
iven ear tags and brands (X; V) for the purpose of identiﬁcation.ogy and Immunopathology 169 (2016) 68–73 69
After application of the skin test and sampling, the animals were
reversed using diprenorphine hydrochloride (M5050, Novartis
Animal Health, Isando, South Africa). The same procedure was
used for immobilisation and reversal of the animals during reading
of the skin test.
2.3. SICTT
The SICTT was performed according to the OIE standards (World
Organisation for Animal Health, 2014). Brieﬂy, an area of skin
(3 × 5 cm)  was shaved on both sides of the neck, skin fold thick-
ness at both injection sites was measured with callipers and 3000IU
of PPD-B (puriﬁed protein derivative of M. bovis) (Prionics AG,
Lelystad, the Netherlands) and 2500IU of PPD-A (puriﬁed protein
derivative of M. avium)  (Prionics AG, Lelystad, the Netherlands)
were injected intradermally in the left and right side of the neck,
respectively. Thirty-ﬁve animals were skin tested and injected on
day 1. Reading of the SICTT took place 72 h (day 4) after injection
of the tuberculin PPDs (puriﬁed protein derivatives). Interpretation
of the SICTT was done according to the guidelines for interpreta-
tion of infected herds as validated locally by the State Veterinary
Ofﬁce of Hluhluwe (McCall, unpublished data). Brieﬂy, an animal is
considered positive when the skin thickness increase at the bovine
injection site is >4 mm and the difference between the skin thick-
ness at bovine and avian sites is ≥ 2 mm;  the reaction is considered
inconclusive when the bovine site shows an increase of >4 mm and
the difference between the bovine and avian sites is between one
and two millimetres; the reaction is considered negative if the dif-
ference between the bovine and avian sites is ≤0-1 mm,  even if the
bovine site shows an increase of >4 mm.
2.4. Sample collection
Whole blood was collected from the jugular vein using a vacu-
tainer system. On day 1, prior to tuberculin injection, whole blood
was collected into serum tubes for serological assays. Serum sam-
ples were left to clot at ambient temperature for 24 h and sera
were harvested and frozen at −20 ◦C until further analysis. On
day 4, whole blood was collected into heparin tubes for IFN-
 assays. Heparin samples were processed within 4–6 h after
collection.
2.5. Bovine IFN- release assays
The stimulations for the B1G assay were carried out in 24-well
cell culture plates (Cellstar® Greiner Bio One). Undiluted hep-
arinised blood was aliquoted into 1.5 ml  per well and stimulated
with 50 l pokeweed mitogen (PWM)  (5 g/ml) (internal positive
control), 60 l PPD-A (1000 IU/ml), 30 l PPD-B (600 IU/ml) (Pri-
onics AG, Lelystad, the Netherlands) and 25 l PPD-F (0.5 mg/ml)
(ARC-Onderstepoort Veterinary Institute). An unstimulated aliquot
of whole blood served as an internal negative control; according to
Michel et al. (2011). The samples were incubated at 37 ◦C for 24 h.
The supernatants were harvested and stored at −20 ◦C until further
analysis. The detection of IFN- and the interpretation of results
were conducted according to the manufacturer’s protocol (Prion-
ics AG, Schlieren-Zurich, Switzerland). Samples were considered
valid for analysis if OD-PWM was ≥0.45 and if OD-neg control was
≤0.35.
The stimulations for the B2G assay were carried out in triplicate
in 96-well cell culture plates (Cellstar® Greiner Bio One). Undi-
luted heparinised blood was aliquoted into 250 l per well and
stimulated with the peptide cocktails PC-EC (0.1 mg/ml) and PC-
HP (0.1 mg/ml) (Prionics AG, Schlieren-Zurich, Switzerland) as well
as PPD-A (1000 IU/ml), PPD-B (600 IU/ml) (Prionics AG, Schlieren-
Zurich, Switzerland) and PWM  (5 g/ml) (internal positive control)
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n volumes of 25 l per antigen. An unstimulated aliquot of whole
lood served as an internal negative control. The samples were
ncubated at 37 ◦C for 24 h. The supernatants were harvested and
tored at −20 ◦C until further analysis. The detection of IFN- and
he interpretation of results were conducted according to the man-
facturer’s protocol (Prionics AG, Schlieren-Zurich, Switzerland).
riteria for valid samples controls were as described for the B1G
ssay.
.6. Serological assay
In the IDEXX TB ELISA, sera were tested in three dilutions; undi-
uted, 1:2 dilution and 1:10 dilution, using the sample diluent of
he test kit. For the remainder of the assay the protocol was fol-
owed as supplied by the manufacturer. Criteria for the test validity
ere an OD-value of ≥0.3 for the positive control and ≤0.2 for
he negative control. The interpretation was done according to
he manufacturer’s protocol, using S/P (sample/positive control)
atios.
.7. Post-mortem examination
All animals testing positive or inconclusive on the SICTT were
ulled and a post-mortem (PM) examination was  carried out.
uring PM examination the carcasses were examined for lesions
haracteristic of BTB as described previously by de Klerk et al., 2010.
ymph nodes of the head and lungs were excised from the carcasses
nd subsequently sliced into 1–2 mm sections using a scalpel blade
or thorough inspection and palpation (de Klerk et al., 2010). The
ungs were removed from the carcasses and inspected and palpated
s a whole as well as after incision in all lobes (de Klerk et al., 2010).
he scoring of macroscopic lesions was slightly adapted (Table 1)
rom de Klerk et al., 2010.
.8. Data analysis
As only SICTT positive animals were culled, further analysis
f test performances was  relative to that of the SICTT. Animals
resenting with tuberculous lesions at post-mortem examination
ere considered true BTB positives and only these were used for
urther analysis of relative test sensitivity. Relative test sensitiv-
ty was calculated as the proportion of true positives correctly
lassiﬁed by the test. Relative sensitivity for the B2G assay was cal-
ulated for three test formats, considering that it can be performed
sing either the PPD antigens or the peptide cocktails in isolation
s stimulatory antigens, or they can all be applied in parallel. The
ssay results of all tests for combined application were interpreted
ither in parallel or in series to determine whether these selected
ombinations could improve overall sensitivity (Lewis et al., 2008).
est agreement was determined by Cohen’s kappa coefﬁcient or
, which allows comparison of two different methods of measure-
ent (Petrie and Watson, 2006).
able 1
coring of macroscopic lesions for BTB. Lymph nodes and lung tissue were carefully
xamined and scored according to the scoring system adapted from de Klerk et al.
2010).
Score Description
0 No visible lesions
0.5 Reactive lymph node but no visible lesions found
1  One to ﬁve lesions of 1–2 mm
2 One to ﬁve lesions of >2 mm or >5 lesions of 1–2 mm
3  TB-like lesions in the majority of tissue slices but some
healthy tissue observed
4  Majority of sectioned tissue presented with TB-like lesionsogy and Immunopathology 169 (2016) 68–73
3. Results
3.1. SICTT
Thirteen out of thirty-ﬁve animals were test-positive in the
SICTT (Table 2a), using the criteria set out. One animal’s result
was inconclusive. The remaining twenty-one animals tested neg-
ative with differences in the increase in skin thickness between
bovine and avian of ≤0-1 mm.  (Data not shown.) Positive respon-
der frequency of the SICTT was  100% (Table 3) as culling was biased
towards SICTT positive animals and thus no PM data for SICTT neg-
ative animals could be collected.
3.2. Post-mortem examination
Post-mortem examination was carried out on the 14 animals
that tested positive or inconclusive on the SICTT. Lesions charac-
teristic of BTB were found in 8 out of these 14 animals (57.1%).
The animal that had an inconclusive test result on the SICTT did not
have lesions. Lesions were mainly found in the bronchial and medi-
astinal lymph nodes, but also lung tissue was frequently affected
(Fig. 1). Most of the affected carcasses had lesion scores of 1–2, one
carcass presented with a lesion score of 4 (Table 2a).
3.3. IFN- assays
Twelve out of thirty-ﬁve animals (34.3%) tested positive in the
B1G (Table 2a), resulting in a relative sensitivity of the B1G assay
of 100% (8/8) (Table 3). Four animals tested positive in the B1G but
did not show lesions on PM.
Thirteen out of thirty-ﬁve animals (37.1%) tested positive in
the B2G (Table 2a). The classic antigen preparations PPD-A and
PPD-B detected M. bovis reactivity in 13 animals. There was reac-
tivity to the peptide cocktail PC-EC in 4 animals, whereas 5 animals
showed reactivity to the peptide cocktail PC-HP. Relative sensitivity
of the B2G assay, taking reactivity to both the PPDs and the pep-
tide cocktails into account, was  75% (6/8) (Table 3). Whereas the
relative sensitivity when taking into account the PPDs alone was
also 75% (6/8), for both cocktails it was  50% (4/8) and when tak-
ing into account either PC-EC or PC-HP reactivity the sensitivities
were 37.5% (3/8) and 50% (4/8), respectively (Table 3). Three ani-
mals tested positive in the B2G using the PPDs, but were negative on
all other assays including SICTT (no PM data available) (Table 2b).
3.4. Serology
The S/P ratios for all diluted samples (both 1:2 as well as 1:10)
yielded negative test outcomes in the IDEXX TB ELISA. The undi-
luted samples did yield S/P ratios above the cut-off levels in 9 out
of thirty-ﬁve animals (25.7%) with S/P-levels ranging between 0.31
and 1.31. The relative sensitivity of the IDEXX TB ELISA was found to
be 37.5% (3/8) (Table 3). Four animals tested positive in the IDEXX
TB ELISA, but were negative in all other assays including SICTT (no
PM data available) (Table 2b).
3.5. Single application of tests
Overall, the SICTT and the B1G assay showed higher individual
sensitivity than the other assays, both with a relative sensitivity
of 100% (Table 3). Fourteen SICTT negative animals tested negative
for all other assays, whereas 7 animals reacted in either the B2G
or the IDEXX TB ELISA (Table 2b). The B2G assay is less sensitive
than the SICTT and the B1G assay, with a relative sensitivity of 75%.
The B2G assay was found to be more sensitive when using PPD-A
and PPD-B (75%) than when based on the peptide cocktails, which
did not add to the overall sensitivity of the B2G assay (Table 3).
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Table  2a
Results of all assays for all culled animals. All results in bold reﬂect positive results or values above cut-off levels. C = circumscribed; D = diffuse; N = necrosis; O = oedematous,
∞  = immeasurable.
Ear tag # SICTT B1G
(ODbov-
ODav)
B2G A&B
(ODbov-
ODav)
B2G HP
(ODhp-
nil)
B2G EC
(ODec-
nil)
IDEXX
(S/P
ratio)
PM
(lesion
score)
 bovine
(mm)
 avian
(mm)
Remarks
B4 10.2 0 D, O. 0.358 0.237 0.107 0.106 −0.036 1
B10  ∞ 0 D, N, O. 1.211 1.176 0.758 0.814 0.036 0
B11  ∞ 0 D, N, O. 0.852 1.169 1.239 0.986 0.609 4
B15  ∞ 0 D, N, O. 0.455 0.420 0.039 0.034 0.418 0
B25  ∞ 0 D, O. 0.045 0.034 0.015 0.029 0.155 0
B32  ∞ 0 D, O. 0.267 0.308 0.083 0.087 0.135 0
B37  6.1 0 D, O. 0.008 0.066 0.026 0.016 1.310 0.5
B41  11.1 0 D, N, O. 0.165 0.143 0.106 0.093 0.662 1
B48  13 0 D, O. 0.150 0.211 0.077 0.092 0.570 1
B53  12.2 0 D, O. 0.266 0.015 0.043 0.026 −0.043 1
B57  ∞ 0 D, N, O. 0.588 0.042 0.009 0.048 −0.090 2
B75  14.5 0 D, N, O. 0.754 
B77  4 0 C. 0.672
B84  10.1 0 D, O. 0.147 
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pig. 1. Post-mortem examination results. The distribution of lesions characteristic
f  BTB in the lymph nodes and lungs (in percentages).
verall, the CMI-based assays (SICTT and IFN- assays) showed a
igher sensitivity than the HI-based assay (IDEXX TB ELISA (37.5%))
Table 3).
.6. Parallel application of tests
Relative sensitivity and test agreement were calculated for
elected combinations of assays (Table 3) (Petrie and Watson,
006). The relative sensitivity for in parallel interpretation of test
ombinations with the SICTT is not shown as this assay had 100%
ensitivity in this study due to the bias towards culling SICTT pos-
tive buffaloes. The highest sensitivity (100%) was achieved using
n parallel testing (Table 3), with any combination of the B1G. A
ombination of B2G and IDEXX TB ELISA achieved a sensitivity of
5%. Using in series testing the combination of SICTT & B1G assay
howed highest sensitivity (100%), while the sensitivity of other test
ombinations was reduced to either 37.5% or 75%. Test agreement
as poor between the IDEXX TB ELISA and all other assays (Table 3).
able 2b
esults of all assays for several SICTT negative animals, with disparate results. SICTT re
ositive  results or values above cut-off levels.
Ear tag # B1G (ODbov-ODav) B2G A&B (ODbov-ODav) 
B40 0.062 0.019 
B54  0.020 −0.001 
B65  −0.045 0.002 
B79  0.025 −0.006 
B83  0.049 0.253 
B85  0.012 0.203 
B86  0.054 0.309 1.172 0.884 1.278 0.108 2
0.302 −0.033 −0.028 −0.052 0
0.253 −0.123 −0.128 −0.096 1
Test agreement was good between the B1G and SICTT (0.878), sub-
stantial between the B1G and B2G (0.690) and moderate between
the B2G and SICTT (0.578) (Table 3).
4. Discussion
The presence of bovine tuberculosis in the Hluhluwe-iMfolozi
Park has potentially signiﬁcant implications for wildlife species in
the park, some of which are either vulnerable or endangered, and
in addition poses a risk to the livestock and people on neighbouring
(communal) farms (Michel et al., 2006). In order to control this
devastating disease there is a dire need for accurate diagnostics.
Diagnostics for bovine tuberculosis in wildlife, however, are faced
with tremendous difﬁculties in terms of practicality, costs and
accuracy (Michel et al., 2011). The SICTT is the most widely used
diagnostic tool for bovine tuberculosis in African buffaloes, but
more recently IFN- release assays have been applied increas-
ingly (Michel et al., 2011). However, the test performances of these
assays, single and in combination have rarely been compared in
an attempt to develop a diagnostic algorithm for BTB in buffaloes
(Grobler et al., 2002, Goosen et al., 2014). In an endemically infected
ecosystem such as the HiP, the quest for test ﬁtness for the intended
purpose tips the ﬁne balance between sensitivity and speciﬁcity,
towards sensitivity. In the light of the HiP buffalo BTB monitor-
ing and control program, where SICTT positive animals are culled
in an attempt to profoundly decrease the prevalence, a potential
overkill i.e. the culling of false positive reactor animals, is consid-
ered an acceptable cost for the beneﬁt of optimum test sensitivity
and a reduction in the risk of BTB transmission within and between
host species. Le Roex et al. (2015), evaluated the success of the
test-and-cull program in the HiP and found that although it has
been effective at reducing the prevalence of BTB in the park, espe-
cially in areas where testing has happened at regular intervals, the
sults are omitted from this table as they were all negative. Results in bold reﬂect
B2G HP (ODhp-nil) B2G EC (ODec-nil) IDEXX (S/P ratio)
−0.080 −0.047 0.738
−0.002 0.000 0.470
−0.008 −0.001 0.365
0.002 −0.001 0.307
−0.044 −0.044 −0.103
−0.065 −0.064 −0.074
0.019 0.013 −0.091
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Table 3
Positive responder frequency of the SICTT and relative sensitivity of single and combined application of assays and test agreement between assays. Sensitivity (%) was
calculated as the proportion of true positives identiﬁed by the test as positive.
Sensitivity (%) SICTT B1G B2G TB ELISA
PPD-A/PPD-B PC-ECa PC-HPa
Single 100 100 75 37.5 50 37.5
SICTT & B1G SICTT & B2G SICTT & TB ELISA B1G & B2G B1G & TB ELISA B2G & TB ELISA
In  parallel n/a n/a n/a 100 100 75
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  0.878 0.578 0.177 
a When both peptide cocktails were used in parallel for stimulation the sensitivit
rogram needs to be optimized further in order to achieve a more
ronounced reduction in prevalence whilst preserving population
iability. This study aimed at comparison of the test performances
f single or combined CMI- and HI-based assays and development
f an apt diagnostic protocol for BTB in African buffaloes applicable
n the ﬁeld.
All assays used in this study are commercially available and have
een validated for use in cattle. The OIE recognizes that the diag-
ostic test validation in wildlife is constrained by difﬁculties such
s accessibility to samples, poor sample quality, lack of species-
peciﬁc reagents, or ﬁnancial restrictions (World Organisation for
nimal Health, 2014). The OIE guideline for validation of diagnostic
ests for infectious diseases applicable to wildlife (Chapter 3.6.7 of
he Validation Guideline of the Terrestrial Manual) therefore pro-
oses that diagnostic assays validated in domestic animal species
an be validated and provisionally recognised in closely related
ildlife species using a small sample size (World Organisation for
nimal Health, 2014), as applied in this study.
Taking into consideration the limited sample size, this study has
hown that the B1G assay showed an apparent superior sensitivity
o the B2G assay at 100% compared to 75%, respectively. Previous
ork on validation of the B1G assay in African buffaloes used a
riple comparative stimulation approach, to increase speciﬁcity by
he inclusion of PPD-F and reported a sensitivity of 86.5% (Michel
t al., 2011). In contrast, in the present study the B1G assay was
nterpreted according to the manufacturer’s protocol to achieve
ighest sensitivity. It should be noted that the sensitivity of the
ICTT was most likely overestimated in this study due to the fact
hat only SICTT positive animals were culled. The sensitivity of the
ICTT applied to African buffaloes in the same setting was  previ-
usly determined to be 80.9% (Jolles et al., 2005). Assuming the
ensitivity in the current study was similar or the same, the test
erformance of the SICTT could possibly be lower than that of the
1G assay. The B2G assay using only the peptide cocktails is not well
uited for the testing strategy in the HiP as it shows a lower sensi-
ivity than the SICTT and both IFN- assays using the PPDs. The B2G
sing the PPDs, although showing a lower sensitivity compared to
he B1G due to the small sample size in this study, yielded posi-
ive results for 3 animals that were negative on all other assays.
heir true infection status remained unknown but the potential
isclassiﬁcation of those animals by other tests cannot be ruled
ut.
Several animals that were not part of the true positive panel
ested positive on one or more of the immunoassays performed in
his study. Four animals tested positive on both BOVIGAM® assays
s well as the SICTT, while they did not present with lesions on
M and were thus deemed TB negative. These animals can either
ave been in early stages of infection, which would explain the
ack of lesions, or alternatively, be false positive reactors creating an
nder- or overestimation of the assay’s sensitivity, respectively. The
election bias created by culling SICTT positive animals only, as well
s classifying no visible lesions (NVL) reactors as TB negative, was
dentiﬁed as a limitation in this study responsible for the sensitivity
o be either over- or underestimated.75 37.5 37.5
0.690 0.123 0.087
 50%.
The SICTT has several limitations, as it requires boma conﬁne-
ment of the animals for a minimum of 72 h and the animals need
to be handled and immobilized twice. Since this is a very costly
procedure and bears a risk to the well-being and life of the ani-
mals, combined testing with the BOVIGAM® assay and the IDEXX
TB ELISA, might offer a more cost-effective and sensitive diagnostic
alternative, requiring a once-off immobilization only.
To maximize sensitivity of immunodiagnosis of M.  bovis infec-
tion in buffaloes we  recommend that the testing strategy includes
the parallel use of the BOVIGAM® 1G assay as this assay has shown
to have a relative sensitivity of 100% in this study. Combination of
the B1G assay with the IDEXX TB ELISA assay is likely to increase
chances of detection of infected animals in disparate stages of dis-
ease and could be ﬁt for the test purpose in HiP. Although the
speciﬁcity of this serological assay has not been assessed in African
buffaloes, a preliminary validation in a small number of sera from
known BTB-negative buffaloes showed that it was  100% speciﬁc
(van der Heijden, unpublished data). This suggests that the four
animals testing positive only in the IDEXX TB ELISA might have
represented anergic reactors, which were no longer capable of
mounting a CMI-response. This could not be conﬁrmed, as these
animals were not culled.
In addition the results of the current study justify further inves-
tigation of the test performance of the SICTT, BOVIGAM® and IDEXX
TB ELISA aiming at full validation of these assays. In such a follow-
up study, in order to avoid a selection bias, not only SICTT positive,
but also SICTT negative yet BOVIGAM®- or IDEXX TB ELISA-positive
animals should be culled and subjected to a thorough post-mortem
examination in order to evaluate the true sensitivity of both the
BOVIGAM®, the IDEXX TB ELISA and the SICTT.
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